Trending Health

In this minisode, Mindy, Ryan, and Jen discuss a few recent newsworthy items including: the latest in COVID-19 vaccines and treatments (00:34), updates on Pfizer’s copay assistance legal battle (03:55) and surprise billing arbitration (06:30), and the start of Medicare Advantage & Part D open enrollment (10:42).

Podcast Tags: COVID-19, vaccines, Medicare, Medicare Advantage, surprise billing, copay assistance, healthcare, healthcare news

Source Links:

· https://www.nytimes.com/2021/09/22/us/politics/pfizer-boosters-fda-authorize.html 

· https://www.fiercebiotech.com/biotech/merck-s-oral-covid-19-antiviral-slashes-hospitalizations-prevents-deaths-phase-3-sparking?mkt_tok=Mjk0LU1RRi0wNTYAAAF_26eZ92mFcnqWj2kp5mJmBNQxAYY92bvbzylD4BZwugrf-Cgj2MFcLKaDtVAgudm2ZoB_CwSBt4ZrAyzpplj9smBgVLNevUxhsi8R6BGMi0nHVRyiqg&mrkid=65631392 

· https://www.nytimes.com/2021/10/01/us/politics/fda-pfizer-children-boosters-moderna-johnson.html  

· https://www.nytimes.com/2021/10/04/us/politics/johnson-vaccine-booster-coronavirus.html?utm_campaign=KHN%3A%20Daily%20Health%20Policy%20Report&utm_medium=email&_hsmi=166828072&_hsenc=p2ANqtz-8zjAA2sq6MFpwO_AjAqN3mJu0jM89LHFfRU55EtZuYIYnmV5vsziga14y_jLNq9u2ehvyvxiaxzg-gkUuJdwpU1kEnoQ&utm_content=166828072&utm_source=hs_email 

· https://www.statnews.com/pharmalot/2021/10/03/pfizer-medicare-kickbacks-copay-assistance-hhs-lawsuit/?mkt_tok=ODUwLVRBQS01MTEAAAF_6kX1RFxQX7PI_L66DtpDUawamai0HLEEnHaSmt0ATcAT48baYoL2p7rxaPINzCrkEAk9mLuHauRXyDDMRtYoSX_PSBrTNdYUWaxBCbB_MBP7 

· https://www.fiercehealthcare.com/hospitals/biden-admin-releases-surprise-billing-rule-detailing-arbitration-process?mkt_tok=Mjk0LU1RRi0wNTYAAAF_3LPxV-4OsO5wC33D-Ukc9RW9RI95pNRuBwRkNX_dt8A2VORhoIb_jcD-w3VtkDYOlDJyq5y4bkGhL5qxE7XWtot6Cxf1QTJD0q4GLQ0HctkjsXzwXg&mrkid=65631392 

· https://www.fiercehealthcare.com/payer/medicare-advantage-premiums-to-decline-slightly-2022-part-d-to-rise-by-nearly-5?utm_medium=nl&utm_source=internal&mrkid=65631392&mkt_tok=Mjk0LU1RRi0wNTYAAAF_1ced-_CJWe5bAtj7FVS_ngBpZ3lN-zDY2ZQ9YV5wwFelcw6QW1Cq5Xscpxj5XgtFnoukouNyaVYOzlGel6ILx5qZ7s4jTqiahM3PoLKrYum0kC1H5A

· https://www.fiercehealthcare.com/payer/unitedhealthcare-aetna-cigna-anthem-medicare-advantage-2022?utm_medium=nl&utm_source=internal&mrkid=65631392&mkt_tok=Mjk0LU1RRi0wNTYAAAF_6kQ3h-pgu8OegBwTgK1RPMvnDGIyyDJF1BWGkxJPnLZ2WZrIySzaQyTSsiK71dcZBDs05tuD4n1hoHunsQ6EP7QqJvbEoDW3ZxuHnMFe0aUt6-wVKg 

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

Mindy McGrath, Healthcare Industry Learning Lead

[email protected]

Ryan Hummel, Executive and Head of Provider Sector

[email protected]

Jen Burke, Healthcare Industry Strategist

[email protected]

The recent proliferation and adoption of digital health technologies is often heralded as a key mechanism in closing the gap when it comes to health disparities. In this episode, Jen and Mindy are joined by special guest DJ O’Connor to discuss equality barriers in digital health and how healthcare leaders can develop more equitable solutions. The pandemic has accelerated the availability and adoption of digital healthcare, socioeconomic disparities prevent vulnerable populations from accessing from these innovations and create a “digital divide” (01:30). Even when access is not an issue, digital healthcare tools may not provide equivalent benefits across users (04:39) and advanced technologies need to be checked for bias (06:31). There are opportunities for improving equity through digital health, both within and beyond the healthcare industry (10:04) – healthcare leaders should be considering the diversity of their user personas and the social disparities that could prevent access when developing new digital solutions (13:25).

Podcast Tags: digital health, telehealth, access, equity, equality, AI, bias, social determinants of health

Source Links:

· https://www.forbes.com/sites/forbestechcouncil/2021/07/13/digital-health-equity-and-how-to-achieve-it-in-a-post-pandemic-world/?sh=1ffed0dd346d 

· https://www.jmir.org/2020/6/e19361/ 

· https://academic.oup.com/cid/article/72/6/913/5919799 

· https://www.healthcareitnews.com/news/telehealth-use-rises-new-trends-highlight-demographic-divides 

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

DJ O’Connor, Manager

[email protected]

Mindy McGrath, Healthcare Industry Advisor

[email protected]

Jen Burke, Healthcare Industry Strategist

[email protected]

In this minisode, Mindy, Ryan, and Jen discuss a few recent newsworthy items including: the Supreme Court’s decision to deny an emergency appeal to block enforcement of a controversial Texas abortion law (00:35), a recent report on Medicare hospital fund insolvency (03:25), and an FDA committee meeting on complex gene therapy safety questions (11:11).

Podcast Tags: reproductive health, gene therapy, Medicare, FDA, healthcare, healthcare news

Source Links:

· https://www.documentcloud.org/documents/21053670-whole-womans-health-v-jackson 

· https://apnews.com/article/texas-courts-us-supreme-court-32ee7ae7eeec9bdfd1471a848c163321?mkt_tok=ODUwLVRBQS01MTEAAAF_VSIHgCfdE15ODT_em382LPs8xDyw7Tdt5XiQod61z5Qds2MuFATJcJIqFe_VJFQxNSCP0DyV-2J2He6Etr31dqXoPxWpMEQ0NMSd6zLv3W6h 

· https://khn.org/morning-breakout/justice-department-urgently-exploring-challenges-to-texas-abortion-ban/?utm_campaign=KHN%3A%20Daily%20Health%20Policy%20Report&utm_medium=email&_hsmi=156849726&_hsenc=p2ANqtz--wYCjNrXiSeZLsMD2D1FlxOK838QoZlq2zllmYMa3diPB0Gr_PUx0C2xUlTqaBxcNg0rh8vYnAN9KJu5k5J83GyeEdEQ&utm_content=156849726&utm_source=hs_email 

· https://www.fiercehealthcare.com/hospitals/medicare-trustees-project-hospital-fund-to-run-out-2026-same-deadline-as-year-before?utm_medium=nl&utm_source=internal&mrkid=65631392&mkt_tok=Mjk0LU1RRi0wNTYAAAF_SsaDIoa_GdEE8dXas08HXrZcaVizqhjTgUD4Cc1xJOl08rgPOFQhafr3v-et6CpfpHRO1MkAlVlHn1eVMS3SSr4N3wZJekLesyJnCrprs6mv6EtTDg 

· https://www.cms.gov/files/document/2021-medicare-trustees-report.pdf 

· https://www.fiercehealthcare.com/hospitals/medicare-s-hospital-fund-running-out-money-experts-have-five-ideas-how-to-help?utm_medium=nl&utm_source=internal&mrkid=65631392&mkt_tok=Mjk0LU1RRi0wNTYAAAF_SsaDIguC05LhKkmI7AXmacZAYwlhUTyS21yLLSKe7y60RiW0e1wxxpPqKy391LBq_QitIwfGV69YxyT8GT0mLoit6JTLv_cdb77KZpSgORMnDHboXQ 

· https://www.fiercebiotech.com/biotech/fda-committee-takes-complex-gene-therapy-safety-questions-novartis-zolgensma-providing?mkt_tok=Mjk0LU1RRi0wNTYAAAF_X6XMggYm6GwfiUwjeCxSBcS8YEf0fg7e8TZBfSI9PiIni3prmR28AdixqveoYcwWYEJU-9MSfyMedLAfah4R0sAXO4hpzX8QBACruYfHQODP1onf9A&mrkid=65631392 

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

Mindy McGrath, Healthcare Industry Learning Lead

[email protected]

Ryan Hummel, Executive and Head of Provider Sector

[email protected]

Jen Burke, Healthcare Industry Strategist

[email protected]

Patient centricity is no longer a buzzword, it\’s redefining how the pharmaceutical industry operates to deliver the best outcomes and experiences for patients. In this episode, Jen is joined by Vynamic London team members Gemma Pfister and Jack Young to discuss opportunities to become more patient centric throughout the medicine development lifecycle. Inclusiveness, empowerment, and partnership are defining featured of a truly patient centric approach (00:41). There are opportunities for improving patient centricity across the entire lifecycle of a product, from development (03:13) to reimbursement (08:35) to commercialization (12:50). Pharmaceutical companies are uniquely positioned to drive and derive value from patient centricity efforts (19:25), but success in the space requires a focus on strategy, digital, and measurement (21:52). Read how Vynamic partnered with a global pharmaceutical company to help change the way the life sciences industry develops patient-focused solutions in the future in our Case Study – Building an Industry-Changing Patient Innovation Hub.

Podcast Tags: patient centricity, patient advocacy, life sciences, pharmaceutical, pharma, HTA

Source Links:

• https://www.zs.com/insights/whats-the-secret-to-becoming-patient-centric
• https://deep-dive.pharmaphorum.com/magazine/market-access-2021/representation-empowerment-patients-centre-medicine-reimbursement/
• https://www.paconsulting.com/industries/life-sciences/patient-centricity/

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

Gemma Pfister, Executive & London Hub Lead

[email protected]

Jack Young, Director

[email protected]

Jen Burke, Healthcare Industry Strategist

[email protected]

Patient centricity is no longer a buzzword, it's redefining how the pharmaceutical industry operates to deliver the best outcomes and experiences for patients. In this episode, Jen is joined by Vynamic London team members Gemma Pfister and Jack Young to discuss opportunities to become more patient centric throughout the medicine development lifecycle. Inclusiveness, empowerment, and partnership are defining featured of a truly patient centric approach (00:41). There are opportunities for improving patient centricity across the entire lifecycle of a product, from development (03:13) to reimbursement (08:35) to commercialization (12:50). Pharmaceutical companies are uniquely positioned to drive and derive value from patient centricity efforts (19:25), but success in the space requires a focus on strategy, digital, and measurement (21:52). Read how Vynamic partnered with a global pharmaceutical company to help change the way the life sciences industry develops patient-focused solutions in the future in our Case Study - Building an Industry-Changing Patient Innovation Hub.

Podcast Tags: patient centricity, patient advocacy, life sciences, pharmaceutical, pharma, HTA

Source Links:

• https://www.zs.com/insights/whats-the-secret-to-becoming-patient-centric
• https://pharmaceuticalcommerce.com/brand-marketing-communications/accelerating-the-drive-toward-patient-centricity/
• https://deep-dive.pharmaphorum.com/magazine/market-access-2021/representation-empowerment-patients-centre-medicine-reimbursement/
• https://www.paconsulting.com/industries/life-sciences/patient-centricity/

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

Gemma Pfister, Executive & London Hub Lead

[email protected]

Jack Young, Director

[email protected]

Jen Burke, Healthcare Industry Strategist

[email protected]

In this minisode, Mindy, Ryan, and Jen discuss a few recent newsworthy items including: the impact of the Delta variant on the healthcare system (00:31), a crackdown on “pay for delay” in the generic space (05:53), and the fight to legalize Medicare copay assistance (09:25).

Podcast Tags: COVID-19, vaccination, drug prices, generics, biosimilars, Medicare, copays, healthcare, healthcare news

Source Links:

· https://khn.org/news/article/unraveling-the-mysterious-mutations-that-make-delta-the-most-transmissible-covid-virus-yet/?utm_campaign=KHN%20-%20Weekly%20Edition&utm_medium=email&_hsmi=145086783&_hsenc=p2ANqtz-_wMcbW2smTDdSj-wS3p_zbkj9-94CHKV6V5ywjwzuhjyXGO0H8kVETf6VE1Yvrz12rRDC2o5XK47oSm4GPuGRDDGIexg&utm_content=145086783&utm_source=hs_email

· https://www.fiercehealthcare.com/hospitals/cdc-brings-back-mask-recommendation-for-vaccinated-people-areas-high-covid-19-spread?mkt_tok=Mjk0LU1RRi0wNTYAAAF-m4fxAqHQ4MivLtindW3Cc8PNGILqc4EfBXo2E676y8IkQESOCK0vHnb_ssj3k-qmWCczjZo0ZeMwrOxCwJI4EOKRz2QqFPX0pHx2cklaUe1VN4Uubw&mrkid=65631392

· https://www.fiercehealthcare.com/hospitals/40-health-systems-requiring-mandatory-covid-19-vaccines-for-their-workforces?mkt_tok=Mjk0LU1RRi0wNTYAAAF-m4fxAoymvTocAxoJ-vI_Th82_qz69B-Y7KeLLWsOSfDtaG6Ky6TXys9xengpmEM7a4sRY6RUxzqqasEK1vsLjWb4AlUo56Bc2WNiLqhxI1_c98qvMg&mrkid=65631392

· https://www.fiercepharma.com/pharma/as-a-way-to-reduce-drug-prices-and-enhance-competition-senate-takes-aim-at-patent?mkt_tok=Mjk0LU1RRi0wNTYAAAF-l2IhJ68_p0hubbl5WsPZvKzWH-gphrkMs_cWo0cUZY0QFbg8QCMK4JZEdEuLM3wQAE9MCShH_znUDZfdQgtNVqq-RG-DA__bHxBYTKvCNP2L4GJXPw&mrkid=65631392

· https://www.fiercehealthcare.com/payer/kaiser-health-plan-files-pay-for-delay-suit-against-merck-over-cholesterol-drugs?utm_medium=nl&utm_source=internal&mrkid=65631392&mkt_tok=Mjk0LU1RRi0wNTYAAAF-loI_MRbfp3bTdFJGct_3ceVIkr2foNg0S57FCXtjbsyW3rOsuQj2fFBF78b_qPm3QVxvgtYb8p7fSLAMC_w9ufVxY0yiKyZxArpNmBRerpKIDzvBKg

· https://khn.org/news/article/pfizer-court-fight-could-legalize-medicare-copays-and-unleash-gold-rush-in-sales/?utm_campaign=KFF-2021-The-Latest&utm_medium=email&_hsmi=145155484&_hsenc=p2ANqtz-9QqVv7WvcPmmVpbKs6jTJ6DwsHglsdexNJOKhu6vKraHpk3zJT-8adi6MlU7WO5iAMBHzKaQyT4u-PHdYbE20b6Q5TRQ&utm_content=145155484&utm_source=hs_email

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

Mindy McGrath, Healthcare Industry Learning Lead

[email protected]

Ryan Hummel, Executive and Head of Provider Sector

[email protected]

Jen Burke, Healthcare Industry Strategist

[email protected]

Climbing COVID-19 vaccination rates have enabled many countries to relax social distancing requirements and business leaders to implement their return to workplace plans. In this episode, Ryan and Jen are joined by Vynamic’s Lauren Scandone and Stefanie Christmas to discuss the importance of culture in developing and executing those plans. The past eighteen months have irrevocably changed how many employers and employees think about work – bringing technology, employee choice, and empathy to the forefront of the discussion (00:54). This discussion about the future of work should also include a discussion of culture, as it is a key driver of both team and business performance (03:13). Although each company’s culture is unique, there are several key areas of focus on the minds of organizations as they think through their culture roadmaps and return to workplace plans – communication and team dynamics (05:37), psychological safety, resilience and trust (06:03), equity and inclusion (07:45), and employee support and wellbeing (08:40). Healthcare industry leaders can jumpstart the incorporation of cultural considerations into their return to workplace planning by thinking through a few key questions (11:30).

For more information on this topic, check out Vynamic’s Insight “COVID-19 Business Response – Phase 4: The Great Culture Reset”.

Podcast Tags: COVID-19, return to work, culture, employee wellbeing, equity and inclusion

Source Links:

· https://vynamic.com/insights/covid-19-business-response-phase-4-the-great-culture-reset/

· https://www.bls.gov/news.release/flex2.htm

· https://www.pwc.com/us/en/library/covid-19/us-remote-work-survey.html

· https://www.gallup.com/workplace/283985/working-remotely-effective-gallup-research-says-yes.aspx

· https://www.nytimes.com/2016/02/28/magazine/what-google-learned-from-its-quest-to-build-the-perfect-team.html

· https://www.fastcompany.com/90636376/4-ways-to-prevent-employee-culture-shock-as-they-return-to-work

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

Lauren Scandone, Executive

[email protected]

Stefanie Christmas, Director

[email protected]

Ryan Hummel, Executive and Head of Provider Sector

[email protected]

Jen Burke, Healthcare Industry Strategist

[email protected]

In this minisode, Mindy, Ryan, and Jen discuss a few recent newsworthy items including: the Biden administration’s interim final rule banning surprise billing (00:35), Walmart’s launch of a private band insulin analog (04:21), and interim trial results for in vivo CRISPR-based genome editing candidate NTLA-2001 (07:00).

Podcast Tags: surprise billing, health insurance, diabetes, drug prices, gene therapy, CRISPR, healthcare, healthcare news

Source Links:

· https://www.fiercehealthcare.com/payer/biden-admin-releases-first-interim-final-rule-to-ban-surprise-medical-bills-sets?mkt_tok=ODUwLVRBQS01MTEAAAF-ELDJl4M5DBFZ7_MJTdaVw2W_WtZeiSWcn

· https://www.beckershospitalreview.com/finance/cms-unveils-surprise-billing-rule-10-things-to-know.html

· https://www.fiercehealthcare.com/finance/walmart-teams-novo-nordisk-to-launch-private-band-analog-insulin?utm_medium=nl&utm_source=internal&mrkid=65631392&mkt_tok=Mjk0LU1RRi0wNTYAAAF9_AB9bhrYERn_F0_Z_CFgnxi3JFoDbFYYjLV3ub090Lsk6j0dRKGECO_qGldwPtxlXqbfHOT4W09v3LzWGRKpmSFxz_j8dNYwt3sqlB5Nr4esKYBRlg

· https://www.statnews.com/pharmalot/2021/06/29/walmart-insulin-novo-nordisk-diabetes/?mkt_tok=ODUwLVRBQS01MTEAAAF9-91CzqJAe-LL33Gy4FjrwKJDFCfhES48aNg7kB7S_naKvfyJrEjqeHn8s6J5z34wAaGJdW4uvctwaadx9b64EBOjreZh8VfoIbEaDj06GnUa

· https://www.fiercebiotech.com/biotech/first-human-trial-results-intellia-shows-world-gene-editing-has-arrived?mkt_tok=Mjk0LU1RRi0wNTYAAAF-BlNHkt2Maf8F2j4tTY34Nbfr768q_-NEJlovuUC8YR5R6kmRnizLOIUHMuBx4yD_H3cwxx1YhNslaO10Zfx505MYvFxg2Zd5w8yFVCJGLpWlyzkEjg&mrkid=65631392

· https://www.statnews.com/2021/06/26/intellia-therapeutics-ntla-2001-data/?utm_source=STATNewsletters&utm_campaign=63bbc01b83-MR_COPY_14&utm_medium=email&utm_term=0_8cab1d7961-63bbc01b83-149847573

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

Mindy McGrath, Healthcare Industry Learning Lead

[email protected]

Ryan Hummel, Executive and Head of Provider Sector

[email protected]

Jen Burke, Healthcare Industry Strategist

[email protected]

Advancement in technologies and scientific platforms have enabled personalized approaches that acknowledge the future of healthcare shouldn’t be “one-size-fits-all”. Jen, Mindy, and Ryan discuss the drivers behind this innovation, and the impact on both the practice and development of therapeutics. The episode opens with a discussion of what’s sparking this demand for personalization (00:45) and key enablers of this future-state in healthcare, including the availability of data (01:57), connections across data sources (02:35), widespread automation (05:38), and proactive treatment (06:58). The potential of personalization isn’t limited to treatment paradigms alone – it can also be seen in how those treatments are developed and delivered (08:32). Precision medicine initiatives have seen early returns (10:12), particularly in oncology (10:27). Development of CAR-T and gene therapies are pushing individualization of therapeutics even further (11:47) – but there are key clinical (12:19) and developmental (13:56) challenges to be overcome in scaling the delivery of these treatments. As the shift toward personalization continues, healthcare leaders should be considering the strategic value potential, organizational resourcing, and required change management (17:25).

Podcast Tags: healthcare, personalization, precision medicine, AI, machine learning, data, gene therapy

Source Links - Below, we've listed links to some of the stories and resources discussed on this show.

· https://medlineplus.gov/genetics/understanding/precisionmedicine/ 

· https://www.fda.gov/medical-devices/in-vitro-diagnostics/precision-medicine 

· https://www.fda.gov/drugs/news-events-human-drugs/personalized-medicine-biological-approach-patient-treatment 

· https://www.pharmaceutical-technology.com/features/precision-medicine-2020/

· https://www.fiercehealthcare.com/tech/industry-voices-digital-twins-humans-are-closer-than-you-think?mkt_tok=Mjk0LU1RRi0wNTYAAAF9PVg2bgjzIuitbODg7932jkjRPktLd39jOVeKvq-xOH74Rfxoo41R3Qc55yhEiwPnzZfa95PbMsJqVadoVllijzgMc5X7T81YSkhZS1fHPC22at6tsZ4&mrkid=158244174

· https://www.forbes.com/sites/blakemorgan/2021/05/03/the-future-of-healthcare-personalization/?sh=3a7eba147e38

· https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-020-02316-w

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

Mindy McGrath, Healthcare Industry Learning Lead

[email protected]

Ryan Hummel, Head of Provider Sector

[email protected]

Jen Burke, Healthcare Industry Strategist

[email protected]

In this minisode, Mindy, Ryan, and Jen discuss a few recent newsworthy items including: the Supreme Court’s ruling to uphold the Affordable Care Act (ACA) (00:35), the announcement of additional mandatory payment models from the Center for Medicare & Medicaid Innovation (CMMI) (04:20), America’s Health Insurance Plans rebranding as “AHIP” (08:13), the Institute of Clinical and Economic Review’s (ICER) decision to investigate the impact of health plan policies on prescription drug costs (11:18), and finally, the FDA approval of Biogen’s Alzheimer’s therapy (15:15).

Podcast Tags: ACA, CMMI, value based care, AHIP, health insurance, ICER, drug prices, Alzheimer’s, healthcare, healthcare news

Source Links:

· https://www.healthcaredive.com/news/supreme-court-upholds-aca-in-7-2-decision-leaving-intact-landmark-us-healt/599060/

· https://www.healthcaredive.com/news/cmmis-fowler-more-mandatory-payment-models-likely/601258/

· https://www.fiercehealthcare.com/payer/ahip-launching-first-rebranding-effort-nearly-2-decades

· https://www.biopharmadive.com/news/icer-insurers-scrutiny-drug-plan-design/600767/

· https://www.fda.gov/drugs/news-events-human-drugs/fdas-decision-approve-new-treatment-alzheimers-disease

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

Mindy McGrath, Healthcare Industry Learning Lead

[email protected]

Ryan Hummel, Executive and Head of Provider Sector

[email protected]

Jen Burke, Healthcare Industry Strategist

[email protected]